ÐÏࡱá>þÿ SUþÿÿÿRÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿì¥ÁÀ ð¿¡bjbjˆ…ˆ… .Pêïêïÿ” ÿÿÿÿÿÿ·ÞÞ8Nbbbÿÿÿÿvvv8®Êävt0®ÄÄÄij³³óõõõõõõ$¤²Vzb³³³³³bbÄÄï.“““³”bÄbÄó“³ó“““Äÿÿÿÿ fDB©CÔÿÿÿÿGL“ßD0t“ГГ“Ðb§8³³“³³³³³“³³³t³³³³ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿг³³³³³³³³Þ þ: Please provide the following information relating to NSCLC patients treated by your Trust in the 3 months, April 2018 to June 2018 inclusive. If data is not held in a sufficient way within your Trust systems, i.e. if for example you are unable to distinguish between cancer type and/or stage, please indicate accordingly within the tables below. Total number treated Stage IIIB/IV NSCLC PatientsIf unable to provide number of stage IIIB/IV NSCLC patients treated, please indicate the level at which data has been provided: Patients with NSCLC Stage IIIB/IV (Stage 3b/4)7 Total number NSCLC patients Other (please specify) Data not held/accessible Of the Stage IIIB/IV NSCLC patients, please indicate the number of patients treated by your Trust in the 3 months April 2018 to June 2018 inclusive, with the following therapies. Total number treated Stage IIIB/IV NSCLC PatientsIf unable to provide number of stage IIIB/IV NSCLC patients treated, please indicate the level at which data has been provided: Docetaxel (mono or combination therapy ) Total number NSCLC patients Other (please specify) Data not held/accessibleAtezolizumab (Tecentriq) Total number NSCLC patients Other (please specify) Data not held/accessibleNivolumab (Opdivo) Total number NSCLC patients Other (please specify) Data not held/accessiblePembrolizumab (Keytruda) Total number NSCLC patients Other (please specify) Data not held/accessible If your trust does not treat these cancers and you refer your patients to another trust, please state to which trust(s) patients are referred: We only treat patients that are for best supportive care. Active treatment is provided by the Christie. Please see contact details below: The Christie NHS Foundation Trust Wilmslow Road Manchester M20 4BX United Kingdom  FOI requests  Information Governance Officer Tel: 0161 446 3000 Email:  HYPERLINK "mailto:FOI@christie.nhs.uk" FOI@christie.nhs.uk    ICD10 C33, C34  Please indicate the number of patients (excluding clinical trial patients) treated with any active anti-cancer drug treatment.  TNM staging for Stage IIIB NSCLC = Any T, N3, M0 or T4, N2, M0; TNM staging for Stage IV NSCLC = Any T, any N, M1 Please include number for both those patients that present at stage III/IV and also those whose cancer has progressed to stage III/IV     :;LM\ r Ž   @ A B C e f ƒ „ £ ¤ Y o ‹   Z [ x y ˜ ™ Ô Õ ò ó   H I f g † ‡  à à á ‘ïØïØïƵƮµ—µ†µ®µ®µ®ïƵƮµ®µ®µ®µ®µ®µ®µ®µ®µ®µ®µ®µ®ï hJ`óhî*øCJOJQJ^JaJ-jhJ`óhÉ/\0JCJOJQJU^JaJ hJ`óhÉ/\ hJ`óhÉ/\CJOJQJ^JaJ#hJ`óhÉ/\5�CJOJQJ^JaJ-jh:lžhÉ/\0JCJOJQJU^JaJ h:lžhÉ/\CJOJQJ^JaJ1�\ ] �   úúåååÍ$¤$Ifa$gdJ`ólÆ ¤$IfgdJ`ólÆ gdÉ/\  B D d e H8888$IflÆ ¶kd$$If–lÖÖF”ÿ” .®#VÿÿÿÿÿÿÿÿFºFË Ö t ÖÿÿÿÿÿòòòÿòòòÖ0ÿÿÿÿÿÿö6öÖ ÿÿÿÿÿÿÖ ÿÿÿÿÿÿÖ ÿÿÿÖ ÿÿÿ4Ö4Ö lBÖaöpÖÿÿÿÿÿòòòÿòòòytJ`óe f g h :""dð¤$IfgdJ`ólÆ Äkd$$If–l4Ö”ÄÖ\”ÿ” .Æ!®#`FV`ºFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`óh ‚ ƒ „ ïï-Ákd$$If–l4Ö”JÖ\”ÿ” .Æ!®# B BFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`ó$IflÆ „ … † ¢ £ çç××$IflÆ dð¤$IfgdJ`ólÆ £ ¤ ¥ Y =88gdÉ/\Ákd$$If–l4Ö”QÖ\”ÿ” .Æ!®# B BFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`óY Z Œ  êêêÒ$¤$Ifa$gdJ`ólÆ ¤$IfgdJ`ólÆ   8 9 Y Z H8888$IflÆ ¶kd$$If–lÖÖF”ÿ¡ 7®#VÿÿÿÿÿÿÿÿFºFË Ö t ÖÿÿÿÿÿòòòÿòòòÖ0ÿÿÿÿÿÿö6öÖ ÿÿÿÿÿÿÖ ÿÿÿÿÿÿÖ ÿÿÿÖ ÿÿÿ4Ö4Ö lBÖaöpÖÿÿÿÿÿòòòÿòòòytJ`óZ [ \ ] :""dð¤$IfgdJ`ólÆ Äkd$$If–l4Ö”ÄÖ\”ÿ¡ 7È!®#`FV`ºFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`ó] w x y ïï-Ákd$$If–l4Ö”JÖ\”ÿ¡ 7È!®# B BFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`ó$IflÆ y z { — ˜ çç××$IflÆ dð¤$IfgdJ`ólÆ ˜ ™ ² =%d¤È$IfgdJ`ólÆ Ákd$$If–l4Ö”QÖ\”ÿ¡ 7È!®# B BFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`ó² ³ Ó Ô Õ ïïï*Äkd$$If–l4Ö”QÖ\”ÿ¡ 7È!®#`FV`ºFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`ó$IflÆ Õ Ö × ñ ò çç××$IflÆ dð¤$IfgdJ`ólÆ ò ó ô õ =%%dð¤$IfgdJ`ólÆ Ákd $$If–l4Ö”QÖ\”ÿ¡ 7È!®# B BFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`óõ    ïï-Ákdü $$If–l4Ö”QÖ\”ÿ¡ 7È!®# B BFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`ó$IflÆ  & ' G H éÙÙÙ$IflÆ d$IfgdJ`ólÆ H I J K :""dð¤$IfgdJ`ólÆ Äkdò $$If–l4Ö”QÖ\”ÿ¡ 7È!®#`FV`ºFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`óK e f g ïï-Ákdð $$If–l4Ö”QÖ\”ÿ¡ 7È!®# B BFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`ó$IflÆ g h i … † çç××$IflÆ dð¤$IfgdJ`ólÆ † ‡   =%d¤È$IfgdJ`ólÆ Ákdæ $$If–l4Ö”QÖ\”ÿ¡ 7È!®# B BFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`ó  ¡ Á  à ïïï*ÄkdÜ $$If–l4Ö”QÖ\”ÿ¡ 7È!®#`FV`ºFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`ó$IflÆ Ã Ä Å ß à çç××$IflÆ dð¤$IfgdJ`ólÆ à á â ã =%%dð¤$IfgdJ`ólÆ ÁkdÚ$$If–l4Ö”QÖ\”ÿ¡ 7È!®# B BFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`óã ÿ ïï-(gdÉ/\ÁkdÐ$$If–l4Ö”QÖ\”ÿ¡ 7È!®# B BFÔ ÷ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿÖÿÿÿÿ2Ö4Ö4Ö lBÖaöpÖ(ÿÿÿÿÿÿÿÿytJ`ó$IflÆ ûp~ö÷øùúûúúúõõõúåvåånkdÆ$$If–lÖÖ”ÿ®#$ÿÿÿÿÿÿÿÿÿÿÿÿ t Ö0ÿÿÿÿÿÿö6öÖÿÿÿÿÖÿÿÿÿÖÿÖÿÿÿÿ4Ö4Ö laöpÖ ÿÿytJ`ó$IflÆ gd¬}=gdÉ/\ ‘’“ùúûp~·¸àáôõö÷øùûüþïáÏÀ±Àœ†œ~z~œdœRG@G@8hÉ/\CJaJ hJ`óhÉ/\hJ`óhÉ/\CJaJ#h:lžh¬}=5�CJOJQJ^JaJ+jh¶YzCJOJQJU^JaJmH sH h¶Yzjh¶YzU+h¤)Zh¬}=5�CJOJQJ^JaJmH sH (h¤)Zh¬}=CJOJQJ^JaJmH sH hÉ/\5�CJOJQJ^JaJh¬}=5�CJOJQJ^JaJ#h:lžhî*ø5�CJOJQJ^JaJh:lžCJOJQJ^JaJ h:lžhî*øCJOJQJ^JaJûüýþÿ’ ’“•–˜™�‹‹‰„„}}‰s‰s‰ dð¤gdÉ/\¤gdÉ/\gdÉ/\gdÉ/\nkdd$$If–lÖÖ”ÿ®#$ÿÿÿÿÿÿÿÿ t Ö0ÿÿÿÿÿÿö6öÖÿÖÿÿÿÿÖÿÖÿÿÿÿ4Ö4Ö laöpÖ ÿÿytJ`ó þÿ‘’“”Ô‘’“”–—™šœ� ¡üòîæòîæîòîÞØîÔÌÔÌÔÌÔÌÔüjh¶YzUh¶Yz hÉ/\CJhÉ/\CJaJhÉ/\CJaJhÉ/\jhÉ/\0JUh:`™›œžŸ ¡õóõóóó dð¤gdÉ/\,1�h°‚. °ÆA!° "° #� $� %°°Ä°Ä �Ä$$If–!vh#v#vš#v€:V –l Ö t ÖÿÿÿÿÿòòòÿòòòÖ0ÿÿÿÿÿÿö65ÖV5Öº5ÖË/Ö ÿÿÿÿÿÿÿÿ/Ö ÿ/Ö ÿ/Ö ÿBÖpÖÿÿÿÿÿòòòÿòòòytJ`óü$$If–!vh#v#vš#v˜ #vè:V –l4”Ä t Ö0ÿÿÿÿÿÿö6+Ö+Ö5ÖV5Öº5ÖÔ 5Ö÷/Ö ÿ2ÖBÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óô$$If–!vh#v#vš#v˜ #vè:V –l4”J t Ö0ÿÿÿÿÿÿö6+Ö+Ö,Ö5Ö5ÖÔ 5Ö÷/Ö ÿ2ÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óô$$If–!vh#v#vš#v˜ #vè:V –l4”Q t Ö0ÿÿÿÿÿÿö6+Ö+Ö,Ö5Ö5ÖÔ 5Ö÷/Ö ÿ2ÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`ó$$If–!vh#v #v–#vw:V –l Ö t ÖÿÿÿÿÿòòòÿòòòÖ0ÿÿÿÿÿÿö65ÖV5Öº5ÖË/Ö ÿÿÿÿÿÿÿÿ/Ö ÿ/Ö ÿ/Ö ÿBÖpÖÿÿÿÿÿòòòÿòòòytJ`óü$$If–!vh#v #v–#v‘ #væ:V –l4”Ä t Ö0ÿÿÿÿÿÿö6+Ö+Ö5ÖV5Öº5ÖÔ 5Ö÷/Ö ÿ2ÖBÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óô$$If–!vh#v #v–#v‘ #væ:V –l4”J t Ö0ÿÿÿÿÿÿö6+Ö+Ö,Ö5Ö5ÖÔ 5Ö÷/Ö ÿ2ÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óô$$If–!vh#v #v–#v‘ #væ:V –l4”Q t Ö0ÿÿÿÿÿÿö6+Ö+Ö,Ö5Ö5ÖÔ 5Ö÷/Ö ÿ2ÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óü$$If–!vh#v #v–#v‘ #væ:V –l4”Q t Ö0ÿÿÿÿÿÿö6+Ö+Ö5ÖV5Öº5ÖÔ 5Ö÷/Ö ÿ2ÖBÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óô$$If–!vh#v #v–#v‘ #væ:V –l4”Q t Ö0ÿÿÿÿÿÿö6+Ö+Ö,Ö5Ö5ÖÔ 5Ö÷/Ö ÿ2ÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óô$$If–!vh#v #v–#v‘ #væ:V –l4”Q t Ö0ÿÿÿÿÿÿö6+Ö+Ö,Ö5Ö5ÖÔ 5Ö÷/Ö ÿ2ÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óü$$If–!vh#v #v–#v‘ #væ:V –l4”Q t Ö0ÿÿÿÿÿÿö6+Ö+Ö5ÖV5Öº5ÖÔ 5Ö÷/Ö ÿ2ÖBÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óô$$If–!vh#v #v–#v‘ #væ:V –l4”Q t Ö0ÿÿÿÿÿÿö6+Ö+Ö,Ö5Ö5ÖÔ 5Ö÷/Ö ÿ2ÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óô$$If–!vh#v #v–#v‘ #væ:V –l4”Q t Ö0ÿÿÿÿÿÿö6+Ö+Ö,Ö5Ö5ÖÔ 5Ö÷/Ö ÿ2ÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óü$$If–!vh#v #v–#v‘ #væ:V –l4”Q t Ö0ÿÿÿÿÿÿö6+Ö+Ö5ÖV5Öº5ÖÔ 5Ö÷/Ö ÿ2ÖBÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óô$$If–!vh#v #v–#v‘ #væ:V –l4”Q t Ö0ÿÿÿÿÿÿö6+Ö+Ö,Ö5Ö5ÖÔ 5Ö÷/Ö ÿ2ÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óô$$If–!vh#v #v–#v‘ #væ:V –l4”Q t Ö0ÿÿÿÿÿÿö6+Ö+Ö,Ö5Ö5ÖÔ 5Ö÷/Ö ÿ2ÖBÖpÖ(ÿÿÿÿÿÿÿÿytJ`óœ$$If–!vh#v$:V –l t Ö0ÿÿÿÿÿÿö65Ö$/Ö  ÿÿÿÿÿÿÿÿ/Ö ÿpÖ ÿÿytJ`óœ$$If–!vh#v$:V –l t Ö0ÿÿÿÿÿÿö65Ö$/Ö ÿ/Ö  ÿÿÿÿÿÿÿÿpÖ ÿÿytJ`ój ˜žžžžžžžž666666666vvvvvvvvv666666>666666666666666666666666666¨6666666666¸666666666666hH66666666666666666666666666666666666666666666666666666666666666666°62ÀÐàð 0@P`p€�ÀÐàð2(Øè 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�8XøV~ OJPJQJ_HmH nH sH tH J`ñÿJ É/\Normal d¤ CJ_HaJmH sH tH DA òÿ¡D Default Paragraph FontRi@óÿ³R 0 Table Normalö4Ö l4Öaö (k ôÿÁ( 0No List H@òH É/\0 Footnote Text dð¤CJaJDþoòÿD É/\0Footnote Text CharCJaJ@&`òÿ@ É/\0Footnote ReferenceH*xš`³#x É/\° Table Grid<:VÖ0ÿÿÿÿÿÿaö dð¤PK!éÞ¿ÿ[Content_Types].xml¬‘ËNÃ0E÷Hüƒå-Jœ²@%é‚ÇŽÇ¢|ÀÈ™$ÉØ²§Uû÷LÒTB¨ l,Ù3÷ž;ãr½µÃ˜œ§J¯òB+$ëG]¥ß7OÙ­V‰�$ùãûÿ©«×îÇ !)OÚ^ýrÍC$ñy@“°íÝö/­yH*œ˜ñ„´½)‘Þµ�÷ß»Š×UDb‚`}"×qÛ‹”J×—–¤ÃX^æ)I`nÌEŒ¼Šp)øèÆli¹V[]Š1M<”àÈÞ�©OÐP“ô6râ=¯‰’zÀgb Ig…Áu��SÙebÖö€OÀ�†ä¾òÃRÁDÛ«™Ÿ·´qu ¯g‹˜Z°¶´®o~ÙºlAp°lxŠpT0­÷­+[}`j×ëõº½zAϰV–2ÍF­ÞÉi–@öqžv·Ö¬5\|‰þʜ̭N§Óle²X¢dsøµÚjcsÙÁ�Å7çð�Îf·»êà ÈâWçðý+­Õ†‹7 ˆÑä`­ÚïgÔ È˜³íJøÀ×j|†‚h(¢K³óD-еß㢠dXÑ©iJÆØ‡(îâx$(Ö ð:Á¥;ä˹!Í I_ÐTµ½S 1£÷êù÷¯ž?EÇž?øéøáÃã?ZBΪmœ„åU/¿ýìÏÇ£?ž~óòÑÕxYÆÿúÃ'¿üüy5Òg&΋/ŸüöìÉ‹¯>ýý»GðM�Geø�ÆD¢›äíó3Vq%'#q¾ÃÓòŠÍ$”8ÁšKýžŠôÍ)f™w9:ĵàå£ x}rÏx‰‰¢œw¢ØîrÎ:\TZaGó*™y8IÂjæbRÆíc|XÅ»‹Ç¿½I u3KGñnD1÷NIBÒsü€� íîRêØu—ú‚K>Vè.EL+M2¤#'šf‹¶i ~™Vé þvl³{u8«Òz‹ºHÈ Ì*„æ˜ñ:ž(W‘☕ ~«¨JÈÁTøe\O*ðtHG½€HYµæ–}KNßÁP±*ݾ˦±‹ŠTѼ�9/#·øA7ÂqZ…Ð$*c?�¢íqUßån†èwðNºû%Ž»O¯·ièˆ4 =3¾¼N¸¿ƒ)cbJ u§VÇ4ù»ÂÍ(TnËáâ 7”Ê_?®�ûm-Ù›°{UåÌö‰B½w²ÒzÏû¨nœ”ÇÊœ"Z úàxŠÕJÜZšìp;‹“Êì ØåÞ{/å<óP;™Ž,)''KÐQÛk5—›òqÚöÆpN†Ç8¯KÝGbÂe“¯„ ûS“ÙdùÌ›­\17 êpõaí>§°SR!Õ–‘ 3•…K4'+ÿrÌzQ TT£³I±²Áð¯Ivt]KÆc⫲³K#Úvö5+¥|¢ˆDÁ±‰ØÇà~ª O@%\w˜Š _ànN[ÛL¹Å9Kºò�˜ÁÙqÌÒgåV§hžÉn R!ƒy+‰ºUÊn”;¿*&å/H•rÿÏTÑû Ü>¬Ú>\ Œt¦´=.TÄ¡ ¥õûS; Zà~¦!¨à‚ÚüäPÿ·9gi˜´†C¤Ú§!ö# Bö ,™è;…X=Û»,I–2UW¦Vì9$l¨kàªÞÛ=A¨›j’•ƒ;î{–A£P79å|s*Y±÷Úø§;›Ì ”[‡MC“Û¿±hf»ª]o–ç{oY=1k³yV³ÒVÐÊÒþ5E8çVk+ÖœÆËÍ\8ðâ¼Æ0X4D)Ü!!ýö?*|f¿vè uÈ÷¡¶"øx¡‰AØ@T_²�ÒÒŽ q²ƒ6˜4)kÚ¬uÒVË7ë ît ¾'Œ­%;‹¿Ïiì¢9sÙ9¹x‘ÆÎ,ìØÚŽ-45xödŠÂÐ8?ÈǘÏdå/Y|t½ß &LILð�J`è¡& ù-G³tã/ÿÿPK! Ñ�Ÿ¶'theme/theme/_rels/themeManager.xml.rels„�M Â0„÷‚wooÓº‘&݈ЭÔ„ä5 6?$Qìí ®,.‡a¾™i»—�Éc2Þ1hª:é•qšÁm¸ìŽ@RN‰Ù;d°`‚Žo7íg‘K(M&$R(.1˜r'J“œÐŠTù€®8£�Vä"£¦AÈ»ÐH÷u} ñ›|Å$½b{Õ–Pšÿ³ý8‰g/]þQAsÙ…(¢ÆÌà#›ªLÊ[ººÄßÿÿPK-!éÞ¿ÿ[Content_Types].xmlPK-!¥Ö§çÀ6 0_rels/.relsPK-!ky–ƒŠtheme/theme/themeManager.xmlPK-!0ÝC)¨¤Ötheme/theme/theme1.xmlPK-! Ñ�Ÿ¶'² theme/theme/_rels/themeManager.xml.relsPK]­ :L@¡ ““–¡ P ÿÿÿÿ ‘þ¡ $& e h „ £ Y  Z ] y ˜ ² Õ ò õ  H K g †   à à ã û™¡  !"#%'·àô¡ Xÿ•ŒðLð# ð †ÁÅÁ@ñÿÿÿ€€€÷ð’ðð0ð( ð ððB ðS ð¿Ëÿ ?𙥧°$‡”–ž?Gÿ“ • – ˜ ™ › œ ž ¢ ÿ“ • – ˜ ™ › œ ž ¢ ì?OLå¬}=É/\:`¶Yz:lž~ÔJ`óî*øÿÿ@€¡ ˆ@ÿÿUnknownÿÿÿÿÿÿÿÿÿÿÿÿG�‡* ÿTimes New Roman5�€Symbol3.� ‡* ÿArial7.�ÿ*à{$À ÿCalibriA�ÿàÿ$BŸCambria Math"1ˆðÐhŒi'Œi'1Î�m%!ð  ´´��0ûŽ JƒðüýHX ðÿ $PäÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÉ/\2!xx  ÜÿÿEnglish-Gallantry GerardGriffiths Pamelaþÿà…ŸòùOh«‘+'³Ù08 pxœ¬ ÈÔ ô   (0äEnglish-Gallantry GerardNormalGriffiths Pamela2Microsoft Office Word@FÃ#@pÞ9©CÔ@pÞ9©CÔ1ÎþÿÕÍÕœ.“—+,ù®DÕÍÕœ.“—+,ù®,è hp|„Œ” œ¤¬´ ¼ ÉäWWLû  Title¸ 8@ _PID_HLINKSäApemailto:FOI@christie.nhs.uk  !"#$%&'(þÿÿÿ*+,-./012þÿÿÿ456789:;<=>?@AþÿÿÿCDEFGHIþÿÿÿKLMNOPQþÿÿÿýÿÿÿTþÿÿÿþÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿRoot Entryÿÿÿÿÿÿÿÿ ÀFpUB©CÔV€Data ÿÿÿÿÿÿÿÿÿÿÿÿ)1Tableÿÿÿÿ3ÐWordDocumentÿÿÿÿ.PSummaryInformation(ÿÿÿÿÿÿÿÿÿÿÿÿBDocumentSummaryInformation8ÿÿÿÿÿÿÿÿJCompObjÿÿÿÿÿÿÿÿÿÿÿÿrÿÿÿÿÿÿÿÿÿÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿ ÿÿÿÿ ÀF Microsoft Word 97-2003 Document MSWordDocWord.Document.8ô9²q